AXSOME THERAPEUTICS INC (AXSM) Stock Balance Sheet
NASDAQ:AXSM - Nasdaq - US05464T1043 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 86.50M | |||
| Cash Equivalents | 300.91M | N/A | 386.19M | 200.80M | N/A | |||
| Receivables | 161.40M | 142.00M | 95.00M | 37.70M | N/A | |||
| Inventories | 16.32M | 16.00M | 15.00M | 4.30M | N/A | |||
| Other Current Assets | 16.01M | 12.00M | 8.12M | 2.80M | 0.00 | |||
| Total Current Assets | 494.63M | 485.00M | 504.00M | 245.60M | 86.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 24.07M | 5.97M | 7.62M | 1.10M | 900.00K | |||
| Goodwill | 12.04M | 12.00M | 12.00M | 10.30M | N/A | |||
| Intangibles | 45.32M | 47.00M | 53.00M | 59.70M | N/A | |||
| Other Non-Current Assets | 20.61M | 19.00M | 11.00M | 14.70M | 300.00K | |||
| Total Non-Current Assets | 102.04M | 83.00M | 84.00M | 85.90M | 1.30M | |||
| TOTAL ASSETS | 596.67M | 568.00M | 588.00M | 331.50M | 87.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.82M | 1.42M | N/A | N/A | N/A | |||
| Accrued Expenses | 146.88M | 147.00M | 92.00M | 52.10M | 9.90M | |||
| Accounts Payable | 85.66M | 72.00M | 41.00M | 38.60M | 13.10M | |||
| Other Current Liabilities | 9.56M | 9.25M | 6.41M | 5.90M | N/A | |||
| Total Current Liabilities | 243.91M | 230.00M | 139.00M | 96.60M | 23.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 185.06M | 184.00M | 178.00M | 94.30M | 49.10M | |||
| Other Non-Current Liabilities | 114.50M | 98.00M | 80.00M | 31.10M | 0.00 | |||
| Total Non-Current Liabilities | 299.55M | 281.00M | 258.00M | 125.30M | 49.10M | |||
| TOTAL LIABILITIES | 543.47M | 511.00M | 397.00M | 221.90M | 72.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.18B | -1.12B | -836.00M | -596.30M | -409.20M | |||
| Additional Paid In Capital | 1.24B | 1.18B | 1.03B | 705.90M | 424.80M | |||
| Common Shares | 5.00K | 10.00K | 10.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 49.22M | 49.00M | 47.00M | 43.50M | 37.80M | |||
| Tangible Book Value per Share | -0.08 | -0.04 | 2.68 | 0.91 | 0.41 | |||
| Total Shareholders' Equity | 53.20M | 57.00M | 191.00M | 109.60M | 15.60M | |||
| TOTAL LIABILITIES AND EQUITY | 596.67M | 568.00M | 588.00M | 331.50M | 87.80M | |||
| Statistics | ||||||||
| Debt/Equity | 3.48 | 3.23 | 0.93 | 0.86 | 3.15 | |||
| Current Ratio | 2.03 | 2.11 | 3.63 | 2.54 | 3.74 | |||
| Return On Assets (ROA) | -46.64% | -50.57% | -40.69% | -56.45% | -148.52% | |||
| Return On Equity (ROE) | -523.02% | -503.89% | -125.26% | -170.74% | -835.90% | |||
All data in USD , ROIC based on taxRate of 0.21